Metcalf P A, Scragg R K
Department of Statistics, University of Auckland, Private Bag 92019, 1, Auckland, New Zealand.
Diabetes Res Clin Pract. 2000 Aug;49(2-3):169-80. doi: 10.1016/s0168-8227(00)00147-9.
The aim was to compare the 1997 American Diabetes Association (ADA) and 1985 and 1998 World Health Organisation (WHO) criteria for the diagnosis of diabetes and impaired glucose tolerance (IGT) by ethnicity and cardiovascular risk factors. We analysed the oral glucose tolerance tests carried out in a cross-sectional survey of 5816 New Zealand workers aged 22-78 years (4211 men, 1605 women) carried out between 1988 and 1990. Prevalence of diabetes was similar using ADA (3.1%) compared with the 1998 WHO criteria (3.0%). The overall prevalence rate of diabetes using the 1985 WHO criteria was only 1.5%. The prevalence rate of impaired fasting glucose (IFG) was the lowest in Europeans (7.3%) and highest in Asians (15.0%). The overall weighted kappa for agreement between the 1997 ADA and 1998 WHO criteria was moderate (0.59), but varied between ethnic groups. Cardiovascular disease (CVD) risk factors were approximately more adverse across groups with IFG, normal (ADA)/IGT (WHO), IFG/IGT and diabetes compared with normal subjects. Compared to those with IFG, participants with the normal (ADA)/IGT (WHO) criteria differed in fasting and 2-h glucose, diastolic blood pressure, and urinary albumin levels, and the proportions of males and number with hypertension, but had a significantly adverse pattern of CVD risk factors compared to those with normal glycaemia. The 1988 WHO criteria using the OGTT provides additional information for classifying various categories of glucose intolerance that is not captured using the 1997 ADA fasting glucose criteria alone.
目的是按种族和心血管危险因素比较1997年美国糖尿病协会(ADA)以及1985年和1998年世界卫生组织(WHO)的糖尿病及糖耐量受损(IGT)诊断标准。我们分析了在1988年至1990年间对5816名年龄在22至78岁的新西兰工人(4211名男性,1605名女性)进行的横断面调查中所开展的口服葡萄糖耐量试验。与1998年WHO标准(3.0%)相比,使用ADA标准时糖尿病患病率相似(3.1%)。使用1985年WHO标准时糖尿病的总体患病率仅为1.5%。空腹血糖受损(IFG)患病率在欧洲人中最低(7.3%),在亚洲人中最高(15.0%)。1997年ADA标准与1998年WHO标准之间一致性的总体加权kappa值为中等(0.59),但在不同种族群体中有所差异。与正常受试者相比,IFG、正常(ADA)/IGT(WHO)、IFG/IGT和糖尿病组的心血管疾病(CVD)危险因素在各群体中大致更不利。与IFG者相比,符合正常(ADA)/IGT(WHO)标准的参与者在空腹及2小时血糖、舒张压和尿白蛋白水平方面存在差异,在男性比例和高血压患者数量方面也存在差异,但与血糖正常者相比,其CVD危险因素模式明显更不利。使用OGTT的1988年WHO标准为分类各种糖耐量异常类别提供了单独使用1997年ADA空腹血糖标准所无法获取的额外信息。